Literature DB >> 26018152

Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.

Georgios Tsouchnikas1, Juergen Zlatkovic1, Johanna Jarmer1, Judith Strauß1, Oksana Vratskikh1, Michael Kundi2, Karin Stiasny1, Franz X Heinz3.   

Abstract

UNLABELLED: The antibody response to proteins may be modulated by the presence of preexisting antigen-specific antibodies and the formation of immune complexes (ICs). Effects such as a general increase or decrease of the response as well as epitope-specific phenomena have been described. In this study, we investigated influences of IC immunization on the fine specificity of antibody responses in a structurally well-defined system, using the envelope (E) protein of tick-borne encephalitis (TBE) virus as an immunogen. TBE virus occurs in Europe and Asia and-together with the yellow fever, dengue, West Nile, and Japanese encephalitis viruses-represents one of the major human-pathogenic flaviviruses. Mice were immunized with a dimeric soluble form of E (sE) alone or in complex with monoclonal antibodies specific for each of the three domains of E, and the antibody response induced by these ICs was compared to that seen after immunization with sE alone. Immunoassays using recombinant domains and domain combinations of TBE virus sE as well as the distantly related West Nile virus sE allowed the dissection and quantification of antibody subsets present in postimmunization sera, thus generating fine-specificity patterns of the polyclonal responses. There were substantially different responses with two of the ICs, and the differences could be mechanistically related to (i) epitope shielding and (ii) antibody-mediated structural changes leading to dissociation of the sE dimer. The phenomena described may also be relevant for polyclonal responses upon secondary infections and/or booster immunizations and may affect antibody responses in an individual-specific way. IMPORTANCE: Infections with flaviviruses such as yellow fever, dengue, Japanese encephalitis, West Nile, and tick-borne encephalitis (TBE) viruses pose substantial public health problems in different parts of the world. Antibodies to viral envelope protein E induced by natural infection or vaccination were shown to confer protection from disease. Such antibodies can target different epitopes in E protein, and the fine specificities of polyclonal responses can differ between individuals. We conducted a mouse immunization study with TBE E protein alone or complexed to monoclonal antibodies specific for each of the three protein domains. We demonstrated that phenomena such as epitope shielding and antibody-induced structural changes can profoundly influence the fine specificity of antibody responses to the same immunogen. The study thus provided important new information on the potential immunomodulatory role of preexisting antibodies in a flavivirus system that can be relevant for understanding individual-specific factors influencing antibody responses in sequential flavivirus infections and/or immunizations.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26018152      PMCID: PMC4505641          DOI: 10.1128/JVI.00938-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques.

Authors:  Francois Villinger; Ann E Mayne; Pavel Bostik; Kazuyasu Mori; Peter E Jensen; Rafi Ahmed; Aftab A Ansari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants.

Authors:  Claire Anne Siegrist
Journal:  Vaccine       Date:  2003-07-28       Impact factor: 3.641

Review 3.  Feedback regulation by IgG antibodies.

Authors:  Birgitta Heyman
Journal:  Immunol Lett       Date:  2003-08-05       Impact factor: 3.685

4.  Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

Authors:  Simona Stäger; James Alexander; Alun C Kirby; Marina Botto; Nico Van Rooijen; Deborah F Smith; Frank Brombacher; Paul M Kaye
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

5.  Conformational changes of the flavivirus E glycoprotein.

Authors:  Ying Zhang; Wei Zhang; Steven Ogata; David Clements; James H Strauss; Timothy S Baker; Richard J Kuhn; Michael G Rossmann
Journal:  Structure       Date:  2004-09       Impact factor: 5.006

6.  Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

Authors:  M C Karlsson; S Wernersson; T Diaz de Ståhl; S Gustavsson; B Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Japanese encephalitis in north Queensland, Australia, 1998.

Authors:  J N Hanna; S A Ritchie; D A Phillips; J M Lee; S L Hills; A F van den Hurk; A T Pyke; C A Johansen; J S Mackenzie
Journal:  Med J Aust       Date:  1999-06-07       Impact factor: 7.738

8.  Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.

Authors:  C Panpitpat; U Thisyakorn; T Chotpitayasunondh; E Fürer; J U Que; T Hasler; S J Cryz
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

9.  Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans.

Authors:  L J Brady; M L van Tilburg; C E Alford; W P McArthur
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

10.  Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens.

Authors:  E J Gosselin; K Wardwell; D R Gosselin; N Alter; J L Fisher; P M Guyre
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

View more
  10 in total

1.  Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.

Authors:  Xu Yang; Jianxun Qi; Ruchao Peng; Lianpan Dai; Ernest A Gould; George F Gao; Po Tien
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

2.  Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.

Authors:  Johannes S Gach; Kane J V Mara; Celia C LaBranche; Marit J van Gils; Laura E McCoy; P J Klasse; David C Montefiori; Rogier W Sanders; John P Moore; Donald N Forthal
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.

Authors:  Jason R Wilson; Jessica A Belser; Juliana DaSilva; Zhu Guo; Xiangjie Sun; Shane Gansebom; Yaohui Bai; Thomas J Stark; Jessie Chang; Paul Carney; Min Z Levine; John Barnes; James Stevens; Taronna R Maines; Terrence M Tumpey; Ian A York
Journal:  Virology       Date:  2017-09-06       Impact factor: 3.616

Review 4.  Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.

Authors:  Jennifer Lambour; Mar Naranjo-Gomez; Marc Piechaczyk; Mireia Pelegrin
Journal:  Emerg Microbes Infect       Date:  2016-08-17       Impact factor: 7.163

Review 5.  The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.

Authors:  Félix A Rey; Karin Stiasny; Marie-Christine Vaney; Mariano Dellarole; Franz X Heinz
Journal:  EMBO Rep       Date:  2017-12-27       Impact factor: 8.807

6.  A novel mechanism of antibody-mediated enhancement of flavivirus infection.

Authors:  Denise Haslwanter; Dieter Blaas; Franz X Heinz; Karin Stiasny
Journal:  PLoS Pathog       Date:  2017-09-15       Impact factor: 6.823

7.  Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines.

Authors:  Catarina E Hioe; Rajnish Kumar; Chitra Upadhyay; Muzafar Jan; Alisa Fox; Vincenza Itri; Kristina K Peachman; Mangala Rao; Lily Liu; Nathan C Lo; Michael Tuen; Xunqing Jiang; Xiang-Peng Kong; Susan Zolla-Pazner
Journal:  Front Immunol       Date:  2018-10-26       Impact factor: 7.561

Review 8.  Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases.

Authors:  Alex F Tang; Gospel Enyindah-Asonye; Catarina E Hioe
Journal:  Vaccines (Basel)       Date:  2021-02-02

9.  A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant.

Authors:  Andrew G Diamos; Mary D Pardhe; Haiyan Sun; Joseph G L Hunter; Jacquelyn Kilbourne; Qiang Chen; Hugh S Mason
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

Review 10.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.